AAAAAA
Results:
1-11
|
Results: 11
Authors:
Aapro, M
Citation: M. Aapro, Pharmacology, EUR J CANC, 37, 2001, pp. S251-S252
Authors:
Aapro, M
Citation: M. Aapro, Interview - Matti Aapro, EUR J CANC, 37(11), 2001, pp. 1329-1329
Authors:
Aapro, M
Rowinsky, E
Citation: M. Aapro et E. Rowinsky, Docetaxel: assessing a range of activity, ANTI-CANC D, 12, 2001, pp. S1-S3
Authors:
Kohne, CH
Grothey, A
Bokemeyer, C
Bontke, N
Aapro, M
Citation: Ch. Kohne et al., Chemotherapy in elderly patients with colorectal cancer, ANN ONCOL, 12(4), 2001, pp. 435-442
Authors:
Sobrero, A
Kerr, D
Glimelius, B
Van Cutsem, E
Milano, G
Pritchard, DM
Rougier, P
Aapro, M
Citation: A. Sobrero et al., New directions in the treatment of colorectal cancer: a look to the future, EUR J CANC, 36(5), 2000, pp. 559-566
Authors:
Aapro, M
Extermann, M
Repetto, L
Citation: M. Aapro et al., Evaluation of the elderly with cancer, ANN ONCOL, 11, 2000, pp. 223-229
Authors:
Extermann, M
Aapro, M
Citation: M. Extermann et M. Aapro, Assessment of the older cancer patient, HEMAT ONCOL, 14(1), 2000, pp. 63
Authors:
Aapro, M
Cull, A
Citation: M. Aapro et A. Cull, Depression in breast cancer patients: The need for treatment, ANN ONCOL, 10(6), 1999, pp. 627-636
Authors:
Nabholtz, JM
Senn, HJ
Bezwoda, WR
Melnychuk, D
Deschenes, L
Douma, J
Vandenberg, TA
Rapoport, B
Rosso, R
Trillet-Lenoir, V
Drbal, J
Molino, A
Nortier, JWR
Richel, DJ
Nagykalnai, T
Siedlecki, P
Wilking, N
Genot, JY
Hupperets, PSGJ
Pannuti, F
Skarlos, D
Tomiak, EM
Murawsky, M
Alakl, M
Riva, A
Aapro, M
Citation: Jm. Nabholtz et al., Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy, J CL ONCOL, 17(5), 1999, pp. 1413-1424
Authors:
Aapro, M
Goldhirsch, A
Citation: M. Aapro et A. Goldhirsch, New paradigms in the treatment of advanced breast cancer - Introduction, SEMIN ONCOL, 25(5), 1998, pp. 1-2
Authors:
Aapro, M
Citation: M. Aapro, Docetaxel versus doxorubicin in patients with metastatic breast cancer whohave failed alkylating chemotherapy: A preliminary report of the randomized phase III trial, SEMIN ONCOL, 25(5), 1998, pp. 7-11
Risultati:
1-11
|